Israeli nuclear medicine developer UltraSPECT has received Food and Drug Administration 510(k) clearance for its Xpress.cardiac package.
Designed to reduce myocardial perfusion SPECT acquisition time by 50% without degrading image quality, Xpress.cardiac employs UltraSPECT's wide-beam reconstruction (WBR) technology to boost throughput and reduce patient motion artifacts, according to the Haifa-based vendor. A diagnostic-quality gated stress image scan can be completed in as few as five minutes, UltraSPECT said.
By AuntMinnie.com staff writers
June 16, 2005
Related Reading
UltraSPECT gets CE Mark, May 24, 2005
UltraSPECT builds client list, September 22, 2004
Copyright © 2005 AuntMinnie.com